CV Sciences, Inc.
CVSI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,935 | $5,442 | $4,472 | $12,938 |
| - Cash | $454 | $1,317 | $611 | $1,375 |
| + Debt | $779 | $442 | $1,528 | $922 |
| Enterprise Value | $6,260 | $4,567 | $5,389 | $12,485 |
| Revenue | $15,705 | $16,004 | $16,205 | $20,048 |
| % Growth | -1.9% | -1.2% | -19.2% | – |
| Gross Profit | $7,168 | $7,085 | $5,550 | $8,616 |
| % Margin | 45.6% | 44.3% | 34.2% | 43% |
| EBITDA | -$1,856 | $3,846 | -$5,658 | -$13,998 |
| % Margin | -11.8% | 24% | -34.9% | -69.8% |
| Net Income | -$2,394 | $3,102 | -$8,214 | -$15,554 |
| % Margin | -15.2% | 19.4% | -50.7% | -77.6% |
| EPS Diluted | -0.014 | 0.02 | -0.06 | -0.14 |
| % Growth | -167.7% | 133.8% | 57.5% | – |
| Operating Cash Flow | -$861 | $2,253 | -$1,885 | -$7,485 |
| Capital Expenditures | -$18 | $0 | $0 | -$35 |
| Free Cash Flow | -$879 | $2,253 | -$1,885 | -$7,520 |